Jcm. Vanderloo et al., USE OF ER-MP12 AS A POSITIVE MARKER FOR THE ISOLATION OF MARINE LONG-TERM IN-VITRO REPOPULATING STEM-CELLS, Experimental hematology, 23(9), 1995, pp. 1002-1010
Monoclonal antibody ER-MP12 defines an antigen (Ag) on murine hematopo
ietic stem cells that is differentially expressed by the various subse
ts in the hematopoietic stem cell compartment. To test whether ER-MP12
could be an asset for further subfractionation of these subsets, we p
hysically sorted our previously defined low-density ER-MP20(-) (i.e.,
Ly-6C(-)) Rhodamine-123(dull) (Rh123(dull)), and wheat germ agglutinin
(dim) (WGA(dim)) Stem cell populations on the basis of ER-MP12 Ag expr
ession. In addition, we determined the distribution of the ER-MP12 Ag
on bone marrow 6 days after 5-FU treatment. Long-term and transiently
repopulating stem cell subsets were both identified in vitro using the
cobblestone area-forming cell (CAFC) assay. The data show that sortin
g on the basis of ER-MP12 improves the separation of primitive and mor
e mature stem cell subsets in the Rh123(dull) but not in the WGA(dim)
subpopulation However, the combination of sorting cells on the basis o
f an intermediate ER-MP12 expression and a low WGA affinity (ER-MP12(m
edium) WGA(dim)) allows an 840-fold enrichment for in vitro long-term
repopulating cells (day-28 CAFC) when compared with unseparated bone m
arrow. The distribution of the ER-MP12 Ag on 5-FU-treated bone marrow
stem cells was similar to that in normal bone marrow stem cells, sugge
sting that the level of Ag expression is not dependent on cell-cycle s
tatus. Together, the combination of ER-MP12 and WGA offers the advanta
ge of a positive selection strategy for hematopoietic stem cells, allo
wing different stem cell subsets to be distinguished on the basis of t
heir primitiveness. Since no mature bone marrow cells are found within
the WGA(dim)ER-MP12(medium) subpopulation, the combination of ER-MP12
and WGA enables hematopoietic stem cells to be highly enriched and th
us makes the use of a cocktail of lineage-specific ic antibodies redun
dant.